Autologous saliva transfusion: treatment for HIV?
The HIV-1 pandemic is a complex mix of diverse epidemics within and between countries and regions of the world, and is undoubtedly the defining public-health crisis of our time. Any therapeutic or prophylactic measure which holds promise or provides clues of eliminating or inhibiting the infection is worthy of investigation. As our body's own saliva is suspiciously escaping from the infection and providing clues regarding the resistance/inhibition of HIV; in this paper, a treatment approach is suggested with the rationale of in vitro effective antiviral action of autogenous saliva may also have a better therapeutic potential by its intravenous administration along with dextran.
Arakeri
Gururaj
G
Department of Oral Maxillofacial and Reconstructive Surgery, Sri Sai College of Dental Surgery, Vikarabad and Craniofacial Unit, FMS Dental Hospital, Andhra Pradesh, India. gururaj.arakeri@gmail.com
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology / Q000635:transmission*; D001691:Biological Therapy / Q000379:methods*; D003911:Dextrans; D015497:HIV-1 / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007275:Injections, Intravenous; D012463:Saliva / Q000737:chemistry / Q000276:immunology* / Q000821:virology
D003911:Dextrans